COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test

OBJECTIVES: Observing the serological cross-reactivity between SARS-CoV-2 and dengue virus (DV), we aimed to elucidate its effect on dengue serodiagnosis and infectivity in a highly dengue-endemic city in India. METHODS: A total of 52 COVID-19 (reverse transcription-polymerase chain reaction [RT-PCR...

Descripción completa

Detalles Bibliográficos
Autores principales: Nath, Himadri, Mallick, Abinash, Roy, Subrata, Kayal, Tathagata, Ranjan, Sumit, Sengupta, Susanta, Sukla, Soumi, Biswas, Subhajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262656/
https://www.ncbi.nlm.nih.gov/pubmed/35811081
http://dx.doi.org/10.1016/j.ijid.2022.07.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262656/
https://www.ncbi.nlm.nih.gov/pubmed/35811081
http://dx.doi.org/10.1016/j.ijid.2022.07.013

Ejemplares similares